Methods and compositions for reducing autofluorescence
US-2024209423-A1 · Jun 27, 2024 · US
US2016289735A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016289735-A1 |
| Application number | US-201514672358-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 30, 2015 |
| Priority date | Mar 30, 2015 |
| Publication date | Oct 6, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method is provided herein, wherein the method of capturing a sperm deoxyribo nucleic acid (DNA) in a sample, comprises contacting a lysis solution to the sample comprising at least a sperm cell or a sperm cell lysate to lyse the sperm cell. The sperm cell or sperm cell lysate comprises a protamine-DNA complex. The method further comprises applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody-protamine-DNA complex. The antibody binding is followed by capturing the antibody-protamine-DNA complex; and isolating and detecting the sperm DNA from the captured antibody-protamine-DNA complex.
Opening claim text (preview).
What is claimed is: 1 . A method of capturing a sperm deoxyribo nucleic acid (DNA) in a biological sample, comprising: contacting a lysis solution to the biological sample comprising at least a sperm cell or a sperm cell lysate comprising a protamine-DNA complex to lyse the sperm cell; applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody-protamine-DNA complex; capturing the antibody-protamine-DNA complex; and detecting the sperm DNA from the captured antibody-protamine-DNA complex. 2 . The method of claim 1 , further comprising removing or sequestering the lysis solution prior to applying the protamine-specific antibody. 3 . The method of claim 1 , wherein the lysis solution comprises a reducing agent, a detergent or combination thereof. 4 . The method of claim 3 , wherein the lysis solution comprises a reducing agent selected from dithiothreitol (DTT), tris(2-carboxyethyl)phosphine (TCEP) or combination thereof. 5 . The method of claim 3 , wherein the lysis solution comprises a detergent selected from sodium dodecyl sulfate (SDS). 6 . The method of claim 3 , wherein the lysis solution comprises 40 mM dithiothreitol (DTT), 0.5% to 2% sodium dodecyl sulfate (SDS) or combinations thereof. 7 . The method of claim 3 , further comprising applying a sequestration agent after cell lysis to sequester detergent prior to applying the protamine-specific antibody to the lysed sperm cell. 8 . The method of claim 7 , wherein the sequestration agent comprises ligand-activated core beads coated with size exclusion shell, alpha-cyclodextrin, size exclusion resin or combinations thereof. 9 . The method of claim 1 , wherein the protamine-specific antibody binds to the protamine-nucleic acid complex during incubation in a range from about 4° C. to about 37° C. 10 . The method of claim 1 , wherein the protamine-specific antibody binds to the protamine-nucleic acid complex during incubation at about 4° C. for a time in a range from about 10 minutes to 4 hrs. 11 . The method of claim 1 , wherein the capturing of the antibody-protamine-DNA complex is achieved by a capturing agent, wherein the capturing agent is pre-coupled with the protamine-specific antibody. 12 . The method of claim 11 , wherein the capturing agent comprises a secondary antibody, agarose beads, paramagnetic beads, protein A, streptavidin, sephadex, glass bead or combinations thereof. 13 . The method of claim 1 , wherein the capturing of the antibody-protamine-DNA complex is achieved by further adding a capturing agent, wherein the capturing agent binds to the protamine-specific antibody. 14 . The method of claim 13 , wherein the capturing agent comprises a secondary antibody, agarose beads, paramagnetic beads, protein A, streptavidin, sephadex, glass bead or combinations thereof. 15 . The method of claim 13 , wherein the capturing agent is a secondary antibody specific to the protamine-specific antibody. 16 . The method of claim 13 , wherein the captured antibody-protamine-DNA complex is washed to remove unbound material and purify the sperm DNA. 17 . The method of claim 16 , further comprising incubating the captured antibody-protamine-DNA complex in an ion exchange resin. 18 . The method of claim 17 , wherein the captured antibody-protamine-DNA complex is incubated at about 95° C. for at least about 10 minutes. 19 . The method of claim 1 , wherein a reporter moiety is coupled to the protamine-specific antibody and wherein the detection of the reporter moiety indicates the presence of sperm DNA in the sample. 20 . The method of claim 19 , wherein the reporter moiety comprises a chromophore moiety, a fluorescent moiety, a phosphorescence moiety, an affinity probe, a magnetic probe, a paramagnetic probe, a metallic probe or combinations thereof. 21 . The method of claim 1 , wherein the detection of the sperm DNA comprises one or more amplification reactions of the sperm DNA. 22 . The method of claim 21 , further comprising analyzing the amplified DNA. 23 . The method of claim 1 , wherein the biological sample further comprises epithelial cells, somatic cells, blood cells, or combinations thereof. 24 . The method of claim 1 , wherein the biological sample is selected from a forensic sample comprising sperm cells. 25 . A method of capturing sperm deoxyribonucleic acid (DNA) in a biological sample, comprising: providing the biological sample comprising at least a sperm cell, a partially lysed sperm cell or a sperm cell lysate, wherein the sperm cell, partially lysed sperm cell or sperm cell lysate comprises a protamine-DNA complex; contacting a lysis solution to the sample to lyse the sperm cell or partially lysed sperm cell; applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody-protamine-DNA complex; capturing the antibody-protamine-DNA complex by adding a capturing agent; and detecting the sperm DNA from the captured antibody-protamine-DNA complex by a DNA amplification reaction. 26 . A method of purifying deoxyribo nucleic acid (DNA) from a biological sample, comprising: providing the sample comprising a protamine-DNA complex; applying at least a protamine-specific antibody to the protamine-DNA complex to form an antibody-protamine-DNA complex; capturing the antibody-protamine-DNA complex using a capturing agent; and purifying DNA from the captured antibody-protamine-DNA complex.
Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor · CPC title
Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title
Single or double stranded nucleic acid binding proteins · CPC title
related to pregnancy or the gonads · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.